Contact this trialFirst, we need to learn more about you.
Mesenchymal Stromal Cells
A-MSC Therapy for Kidney Transplant Rejection
Recruiting1 awardPhase 1
Rochester, Minnesota
This trial is testing a new treatment for kidney transplant patients. The treatment is an infusion of allogeneic adipose-derived mesenchymal stromal cells (allo-A-MSC) directly into the renal artery. The purpose of the trial is to see if the treatment is safe and can help reduce inflammation in the transplanted kidney and treat rejection.
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.